Feb 9, 2026 01:43PM
Feb 9, 2026 08:01AM
Jan 21, 2026 09:08AM
Jan 5, 2026 08:01AM
Dec 1, 2025 06:35AM
Nov 26, 2025 05:06PM
Nov 13, 2025 09:26AM Humacyte (HUMA) PT Lowered to $11 at Benchmark
Nov 12, 2025 07:07AM
Oct 6, 2025 08:04AM
Sep 29, 2025 08:01AM
Sep 18, 2025 07:03AM
Sep 15, 2025 07:01AM
Sep 12, 2025 05:06PM
Aug 27, 2025 12:59AM Barclays Starts Humacyte (HUMA) at Overweight
Aug 12, 2025 09:47AM
Aug 12, 2025 09:44AM
Aug 12, 2025 06:42AM
Aug 11, 2025 09:41AM
Aug 11, 2025 07:05AM
Jul 8, 2025 08:10AM
May 14, 2025 09:49AM Humacyte (HUMA) PT Lowered to $14 at Benchmark
May 13, 2025 07:33AM
Apr 3, 2025 09:50AM
Mar 31, 2025 08:26AM
Mar 28, 2025 07:41AM
Mar 27, 2025 06:00PM
Mar 26, 2025 03:41PM
Mar 25, 2025 08:39PM Humacyte (HUMA) Announces Pricing of Public Offering of Common Stock
Mar 25, 2025 04:01PM
Mar 10, 2025 11:40AM
Mar 10, 2025 08:02AM
Mar 7, 2025 09:29AM
Feb 27, 2025 08:02AM
Feb 26, 2025 08:02AM
Jan 28, 2025 08:07AM Humacyte (HUMA) and Pluristyx Announce Gene Editing Partnership
Jan 21, 2025 08:05AM
Jan 16, 2025 05:42PM
Jan 16, 2025 04:41PM
Jan 15, 2025 04:37PM
Jan 13, 2025 09:12PM
Jan 13, 2025 06:53PM
Jan 12, 2025 09:11PM HUMA DEADLINE: ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Humacyte, Inc. Investors to Secure Counsel Before Important January 17 Deadline in Securities Class Action - HUMA
Jan 12, 2025 08:52AM
Jan 11, 2025 03:52PM
Jan 10, 2025 03:52PM
Jan 9, 2025 02:10PM
Jan 7, 2025 04:30PM
Jan 6, 2025 05:51PM
Jan 6, 2025 04:24PM ROSEN, A RANKED AND LEADING FIRM, Encourages Humacyte, Inc. Investors to Secure Counsel Before Important January 17 Deadline in Securities Class Action - HUMA
Jan 5, 2025 12:12PM

341,965 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All